Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals Revenue

Tarsus Pharmaceuticals had revenue of $42.56M in the twelve months ending March 31, 2024, with 53.22% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $27.61M with 1,004.56% year-over-year growth. In the year 2023, Tarsus Pharmaceuticals had annual revenue of $17.45M.

• Revenue (ttm): $42.56M
• Revenue Growth: +53.22%
• P/S Ratio: 24.00
• Revenue / Employee: $174,430
• Employees: 244
• Market Cap: 1.02B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	17.45M	-8.37M	-32.42%
Dec 31, 2022	25.82M	-31.21M	-54.73%
Dec 31, 2021	57.03M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.